Online citations, reference lists, and bibliographies.
← Back to Search

CPPM 2013 Onward: Building A Socio-Technical GPS For Global Personalized Medicine - A Welcome To Editors-In-Chief Adrián LLerena (Spain) And Ross A. McKinnon (Australia)

V. Ozdemir, A. Llerena, R. McKinnon, S. Srivastava, E. Dove, L. Ferguson, M. Masellis, B. Nair, D. Gurwitz, L. Warnich
Published 2013 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Pharmacogenomics, personalized medicine and global health are hot topics. They represent enormously active areas of research and development (R&D) and are situated at the epicenter of the genomics innovation and investment agenda, both in developed and resource-limited countries [3]. The theme of “personalization” is taking on global significance in healthcare, not only in the case of drug therapy but also for other interventions such as vaccines and nutrition as well as targeted diagnostics and screening programs for early disease detection and preventive medicine. A fine example of the latter includes testing for deleterious mutations in
This paper references
10.2217/pgs.10.55
Applying the genome to national drug formulary policy in the developing world.
M. Roederer (2010)
10.1504/IJEH.2010.036209
Mobile phone technologies and advanced data analysis towards the enhancement of diabetes self-management
I. Kouris (2010)
10.2174/187569211794728841
Asia-Pacific Health 2020 and Genomics without Borders: Co-Production of Knowledge by Science and Society Partnership for Global Personalized Medicine.
V. Ozdemir (2011)
10.2174/1875692110907030149
Pharmacogenomics and Personalized Medicine for the Developing World - Too Soon or Just-in-Time? A Personal View from the World Health Organization
T. Pang (2009)
10.1111/j.1365-2362.2009.02232.x
Personal genomics: information can be harmful
D. Ransohoff (2010)
10.1016/S0169-7218(10)01009-9
Open User Innovation
E. Hippel (2010)
10.1089/omi.2013.0034
Crowd-funded micro-grants for genomics and "big data": an actionable idea connecting small (artisan) science, infrastructure science, and citizen philanthropy.
Vural Özdemir (2013)
10.1111/j.1467-9566.2011.01348.x
Enterprising or altruistic selves? Making up research subjects in genetics research.
R. Tutton (2011)
10.1136/bmj.331.7511.246
Tackling the political determinants of global health
I. Kickbusch (2005)
10.2217/pgs.13.10
Beyond the clinic: 'direct-to-consumer' genomic profiling services and pharmacogenomics.
B. Prainsack (2013)
10.1097/GIM.0b013e3182265bed
Is there a need for PGxceptionalism?
M. Khoury (2011)
10.1097/GIM.0b013e3181f9ad55
Evidence-based classification of recommendations on use of genomic tests in clinical practice: Dealing with insufficient evidence
M. Khoury (2010)
10.1126/science.1210025
Moving Toward Global Science
S. Suresh (2011)
10.1016/S0009-9236(99)70006-8
The science of pharmacological variability: An essay
W. Kalow (1999)
10.1038/490337a
Research funding: Global challenges need global solutions
S. Suresh (2012)
10.1098/rsif.2009.0055.focus
The ethical landscape: identifying the right way to think about the ethical and societal aspects of synthetic biology research and products
S. Yearley (2009)
10.1093/CLINCHEM/37.1.119
A new look at the role of urinalysis in the history of diagnostic medicine.
W. White (1991)
10.2174/187569211798377153
Towards an Ecology of Collective Innovation: Human Variome Project (HVP), Rare Disease Consortium for Autosomal Loci (RaDiCAL) and Data-Enabled Life Sciences Alliance (DELSA).
V. Ozdemir (2011)
10.2174/187569211794728850
Personalized Medicine in the Age of Pharmacoproteomics: A Close up on India and Need for Social Science Engagement for Responsible Innovation in Post-Proteomic Biology.
P. J. Reddy (2011)
10.1089/tmj.2009.0153
Developing next-generation telehealth tools and technologies: patients, systems, and data perspectives.
M. Ackerman (2010)
10.1371/journal.pgen.1000993
Web-Based, Participant-Driven Studies Yield Novel Genetic Associations for Common Traits
N. Eriksson (2010)
10.2174/1875692111201010007
Editorial (An Idea Whose Time Has Come? An African Foresight Observatory on Genomics Medicine and Data-Intensive Global Science)
Collet Dandara (2012)
10.1067/mcp.2001.116714
Pharmacogenetics, pharmacogenomics, and pharmacobiology
W. Kalow (2001)
10.1080/03602530801952864
From Human Genetics and Genomics to Pharmacogenetics and Pharmacogenomics: Past Lessons, Future Directions
D. W. Nebert (2008)
10.1185/030079905X50633
Pharmacogenomics: questions and concerns
U. Mahlknecht (2005)
10.2217/PME.13.10
All the post-genomic world is a stage: the actors and narrators required for translating pharmacogenomics into public health.
E. Dove (2013)
10.1126/SCIENCE.124.3220.484-A
Enzymatic deficiency in primaquine-sensitive erythrocytes.
A. Alving (1956)
10.2174/1875692111201010001
End of the Beginning and Public Health Pharmacogenomics: Knowledge in 'Mode 2' and P5 Medicine.
V. Ozdemir (2012)
10.1385/1-59259-928-1:003
An Historical Perspective on the Clinical Diagnostic Laboratory
R. Moore (2006)
10.3390/jpm2030093
Health 2050: The Realization of Personalized Medicine through Crowdsourcing, the Quantified Self, and the Participatory Biocitizen
M. Swan (2012)
10.1371/journal.pmed.1001402
Adapting Standards: Ethical Oversight of Participant-Led Health Research
E. Vayena (2013)
10.4000/kernos.411
Detienne Marcel, Les jardins d’Adonis. La mythologie des parfums et des aromates en Grèce et Les dieux d’Orphée
A. Motte (2007)



Semantic Scholar Logo Some data provided by SemanticScholar